87 related articles for article (PubMed ID: 17252190)
1. The roles of acid-sensing ion channel 1a and ovarian cancer G protein-coupled receptor 1 on passive Mg2+ transport across intestinal epithelium-like Caco-2 monolayers.
Thongon N; Ketkeaw P; Nuekchob C
J Physiol Sci; 2014 Mar; 64(2):129-39. PubMed ID: 24375028
[TBL] [Abstract][Full Text] [Related]
2. Intestinal absorption of bioactive oligopeptides: paracellular transport and tight junction modulation.
Yu Z; Liu D; Wu C; Zhao W
Food Funct; 2024 May; ():. PubMed ID: 38787733
[TBL] [Abstract][Full Text] [Related]
3. Absorption and transport properties of a codfish-derived peptide and its protective effect on bone loss in ovariectomized mice.
Yang M; Su S; Cheng S; Wang Z; Du M
Food Funct; 2024 Apr; 15(7):3496-3506. PubMed ID: 38463011
[TBL] [Abstract][Full Text] [Related]
4. Paracellular absorption is relatively low in the herbivorous Egyptian spiny-tailed lizard, Uromastyx aegyptia.
McWhorter TJ; Pinshow B; Karasov WH; Tracy CR
PLoS One; 2013; 8(4):e61869. PubMed ID: 23596529
[TBL] [Abstract][Full Text] [Related]
5. Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa.
Palić S; Kip AE; Beijnen JH; Mbui J; Musa A; Solomos A; Wasunna M; Olobo J; Alves F; Dorlo TPC
J Antimicrob Chemother; 2020 Nov; 75(11):3260-3268. PubMed ID: 32780098
[TBL] [Abstract][Full Text] [Related]
6. Structure and Antiparasitic Activity Relationship of Alkylphosphocholine Analogues against
Ahmed H; Carter KC; Williams RAM
Microorganisms; 2020 Jul; 8(8):. PubMed ID: 32722326
[TBL] [Abstract][Full Text] [Related]
7. Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms.
Botschuijver S; van Diest SA; van Thiel IAM; Saia RS; Strik AS; Yu Z; Maria-Ferreira D; Welting O; Keszthelyi D; Jennings G; Heinsbroek SEM; Elferink RPO; Schuren FHJ; de Jonge WJ; van den Wijngaard RM
Sci Rep; 2019 Aug; 9(1):12530. PubMed ID: 31467355
[TBL] [Abstract][Full Text] [Related]
8. Oral Nonviral Gene Delivery for Chronic Protein Replacement Therapy.
Lin PY; Chiu YL; Huang JH; Chuang EY; Mi FL; Lin KJ; Juang JH; Sung HW; Leong KW
Adv Sci (Weinh); 2018 Aug; 5(8):1701079. PubMed ID: 30128227
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous population pharmacokinetic modelling of plasma and intracellular PBMC miltefosine concentrations in New World cutaneous leishmaniasis and exploration of exposure-response relationships.
Kip AE; Castro MDM; Gomez MA; Cossio A; Schellens JHM; Beijnen JH; Saravia NG; Dorlo TPC
J Antimicrob Chemother; 2018 Aug; 73(8):2104-2111. PubMed ID: 29757380
[TBL] [Abstract][Full Text] [Related]
10. Functional Validation of ABCA3 as a Miltefosine Transporter in Human Macrophages: IMPACT ON INTRACELLULAR SURVIVAL OF LEISHMANIA (VIANNIA) PANAMENSIS.
Dohmen LC; Navas A; Vargas DA; Gregory DJ; Kip A; Dorlo TP; Gomez MA
J Biol Chem; 2016 Apr; 291(18):9638-47. PubMed ID: 26903515
[TBL] [Abstract][Full Text] [Related]
11. Quantification of miltefosine in peripheral blood mononuclear cells by high-performance liquid chromatography-tandem mass spectrometry.
Kip AE; Rosing H; Hillebrand MJ; Castro MM; Gomez MA; Schellens JH; Beijnen JH; Dorlo TP
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 998-999():57-62. PubMed ID: 26160472
[TBL] [Abstract][Full Text] [Related]
12. In vitro transport characteristics of EFdA, a novel nucleoside reverse transcriptase inhibitor using Caco-2 and MDCKII cell monolayers.
Zhang W; Parniak MA; Sarafianos SG; Empey PE; Rohan LC
Eur J Pharmacol; 2014 Jun; 732():86-95. PubMed ID: 24690257
[TBL] [Abstract][Full Text] [Related]
13. Trans-epithelial transport of the betalain pigments indicaxanthin and betanin across Caco-2 cell monolayers and influence of food matrix.
Tesoriere L; Gentile C; Angileri F; Attanzio A; Tutone M; Allegra M; Livrea MA
Eur J Nutr; 2013 Apr; 52(3):1077-87. PubMed ID: 22806766
[TBL] [Abstract][Full Text] [Related]
14. Intestinal absorption of miltefosine: contribution of passive paracellular transport.
Ménez C; Buyse M; Dugave C; Farinotti R; Barratt G
Pharm Res; 2007 Mar; 24(3):546-54. PubMed ID: 17252190
[TBL] [Abstract][Full Text] [Related]
15. Modulation of intestinal barrier properties by miltefosine.
Menez C; Buyse M; Chacun H; Farinotti R; Barratt G
Biochem Pharmacol; 2006 Feb; 71(4):486-96. PubMed ID: 16337152
[TBL] [Abstract][Full Text] [Related]
16. Inward translocation of the phospholipid analogue miltefosine across Caco-2 cell membranes exhibits characteristics of a carrier-mediated process.
Ménez C; Buyse M; Farinotti R; Barratt G
Lipids; 2007 Apr; 42(3):229-40. PubMed ID: 17393228
[TBL] [Abstract][Full Text] [Related]
17. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
18. Cellular transport and lipid interactions of miltefosine.
Barratt G; Saint-Pierre-Chazalet M; Loiseau PM
Curr Drug Metab; 2009 Mar; 10(3):247-55. PubMed ID: 19442087
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
